Vaccines and Infectious Diseases
Accelerating progress in vaccines and infectious disease research
VaxTrials is Emmes CRO's vaccine and infectious disease center of excellence.
We have been developing and conducting VID interventional and non-interventional studies for over 35 years. With a track record of 650+ clinical trials managed and 350+ journals co-authored, our work has contributed to a number of important vaccines being licensed.
Our therapeutic expertise spans a wide range of conditions. For the past four decades, our infectious disease team has contributed to studies on nearly every major health crisis, including HIV, H1N1, Zika, SARS, MERS, and COVID-19.

Our Operational Model

Project Management
Seamless end-to-end oversight, following a structured and systematic approach, to ensure integrated and efficient project delivery.
Quality Framework
Enhanced trials through analytic and risk-based solutions, while ensuring robust processes and well-trained resources.
Recruitment and Adherence
Participant-centered approach with data driven planning and decision making, encouraging participant adherence.
Tech and AI Enabled
Utilizing AI to transform trial protocols into structured elements for automated eCRF creation, as well as enhancing efficiency and accuracy in trial management.

Outcomes
High Quality Standards
Efficient Recruitment
High Adherence
Fast Database Lock
Our Achievements
Being enabled by Emmes Group's technology and AI capabilities allow us to adopt a quick and agile approach, combined with local knowledge, our operational model, our innovative solutions and flexible mindset, we deliver fast startup, efficient recruitment, high adherence, high-quality standards and fast database lock. All crucial factors for the success of VID trials.
Retention — 92% pediatric, 95% adults
Recruitment Progress (achieved target versus planned)
Recruitment Target (current enrollment versus baseline planned)
Visits completed within window — 91% pediatric, 94% adults
Vaccine and Infectious Diseases Leaders
Our Experience, Your Advantage
Global Footprint with Local Staff
End-to-End Use of Technology and AI
Fast Start-Up Times
High Recruitment and Retention Rates
Solid Network of Investigators


Let's Connect
Schedule a Meeting
Let's discuss how our vaccines and infectious diseases expertise can support your next study.
- Speak with a vaccines and infectious diseases expert
- Tailored solutions for your study needs
- Quick and easy scheduling
Resources
Explore Helpful Resources
Access documents and insights to learn more about our capabilities.


